Program Project (P01) Grant (Discontinued)

NIH Program Project (P01) Grant Mechanism for HCC Research is sponsored by National Cancer Institute (NCI). This funding opportunity invites grant applications that address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC), propose development of animal models for HCC, novel approaches to prevent HCC malignancy, therapeutic or diagnostic tools for reliable prognostic indicators for HCC, and/or develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. Microwave ablation as a therapeutic approach would be relevant.

Investigator-Initiated Program Project (P01) Grants is sponsored by National Cancer Institute (NCI) / National Institutes of Health (NIH). This Funding Opportunity Announcement invites applications for investigator-initiated program project (P01) grants. Proposed program projects may address any of the broad areas of cancer research, including cancer biology, treatment, diagnosis, prevention, and control.

Research Program Projects (P01) is a grant from the National Institutes of Health (NIH) that funds broadly based, multidisciplinary, often long-term research programs organized around a specific major objective or central theme. The grant supports groups of researchers conducting interrelated projects that collectively advance a well-defined research goal, rather than narrower individual investigations. Each component project must contribute to the program's common theme and demonstrate unity and interdependence with other projects. Support can include clinical components and shared basic resources that facilitate the total research effort. Eligible applicants are U.S. institutions with the capacity to conduct large-scale multidisciplinary research. Participating institutes include the National Cancer Institute, National Heart, Lung, and Blood Institute, and National Institute of Allergy and Infectious Diseases. Award amounts vary.

National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI) - NIH. This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated Program Project (P01) applications addressing broad areas of cancer research, including cancer biology, prevention, diagnosis, treatment, and control. Applications must consist of at least three research projects and an Administrative Core, all sharing a common central theme.